On September 1st, Remko van Leeuwen CEO of Madam Therapeutics, gave a pitch and was interviewed on the “Zaken doen met” radioshow on the Dutch Radio Station BNR.
Germany together with a number of countries and foundations today pledged EUR 56.5 million to help develop new treatments to fight against antibiotic resistance, during a fundraising event for the Global Antibiotic Research and Development Partnership (GARDP), hosted in Berlin by the German Federal Ministry of Health and the German Federal Ministry of Education and Research.
In April 2017, a carbapenemase-producing Enterobacteriaceae (CPE) research plan was finalized by a consortium of Dutch research partners, coordinated by Immuno Valley, and commissioned by the Ministry of Economic Affairs.
Combating antibiotic resistance – A Policy Roadmap to Reduce Use of Medically Important Antibiotics in Livestock. Report from the Expert Commission on Addressing the Contribution of Livestock to the Antibiotic Resistance Crisis 2017.
On 24 August, the Access to Medicine Foundation published the methodology for its 2018 Antimicrobial Resistance Benchmark. It is the first independently developed framework for evaluating how pharmaceutical companies are taking action to limit antimicrobial resistance (AMR). The framework was developed through consultation with stakeholders and experts working in AMR to build consensus on the priorities for pharmaceutical companies in AMR.
This summer, the European Commission adopted a new Action Plan to tackle Antimicrobial Resistance (AMR) – a growing threat that is responsible for 25,000 deaths and a loss of €1.5 billion in the EU every year.